Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
Haen S, Löffler M, Rammensee H, Brossart P
NAT REV CLIN ONCOL. 2020;17(10):595-610.

Tumorvakzinierung – therapeutische Vakzinierung gegen Krebs
Rammensee H, Löffler M, Walz J, Bokemeyer C, Haen S, Gouttefangeas C
INTERNIST. 2020;61(7):690-698.

Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma

GENOME MED. 2019;11(1):28.

Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation
Axt L, Naumann A, Toennies J, Haen S, Vogel W, Schneidawind D, Wirths S, Moehle R, Faul C, Kanz L, Axt S, Bethge W
BONE MARROW TRANSPL. 2019;54(11):1805-1814.

A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
Löffler M, Nussbaum B, Jäger G, Jurmeister P, Budczies J, Pereira P, Clasen S, Kowalewski D, Mühlenbruch L, Königsrainer I, Beckert S, Ladurner R, Wagner S, Bullinger F, Gross T, Schroeder C, Sipos B, Königsrainer A, Stevanović S, Denkert C, Rammensee H, Gouttefangeas C, Haen S
FRONT IMMUNOL. 2019;10:2526.

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
Rammensee H, Wiesmüller K, Chandran P, Zelba H, Rusch E, Gouttefangeas C, Kowalewski D, Di Marco M, Haen S, Walz J, Gloria Y, Bödder J, Schertel J, Tunger A, Müller L, Kießler M, Wehner R, Schmitz M, Jakobi M, Schneiderhan-Marra N, Klein R, Laske K, Artzner K, Backert L, Schuster H, Schwenck J, Weber A, Pichler B, Kneilling M, la Fougère C, Forchhammer S, Metzler G, Bauer J, Weide B, Schippert W, Stevanović S, Löffler M
J IMMUNOTHER CANCER. 2019;7(1):307.

Professional and Functional Diversification of the Historic ἰατρός: Implications for Modern Medicine
Haen S
2018. Jesus der Heiler und die Gesundheitsgesellschaft. Wendte M (eds.). 1. ed. Leipzig: Evangelische Verlagsanstalt, 207-224.

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation
Löffler M, Kowalewski D, Backert L, Bernhardt J, Adam P, Schuster H, Dengler F, Backes D, Kopp H, Beckert S, Wagner S, Königsrainer I, Kohlbacher O, Kanz L, Königsrainer A, Rammensee H, Stevanović S, Haen S
CANCER RES. 2018;78(16):4627-4641.

First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications
Löffler M, Steinhilber J, Hilke F, Haen S, Bösmüller H, Montes-Mojarro I, Bonzheim I, Stäbler A, Faust U, Grasshoff U, Königsrainer I, Rammensee H, Kanz L, Königsrainer A, Beckert S, Riess O, Schroeder C
BMC MED GENET. 2018;19(1):144.

Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells
Maurer S, Kropp K, Klein G, Steinle A, Haen S, Walz J, Hinterleitner C, Märklin M, Kopp H, Salih H
ONCOIMMUNOLOGY. 2018;7(2):e1364827.

Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer
Yurttas C, Hoffmann G, Tolios A, Haen S, Schwab M, Königsrainer I, Königsrainer A, Beckert S, Löffler M
J CLIN MED. 2018;7(12):.

Vessels, T cells, and GVHD: time matters
Haen S
BLOOD. 2017;129(14):1898-1899.

Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies
Haen S, Eyb V, Mirza N, Naumann A, Peter A, Löffler M, Faul C, Vogel W, Bethge W, Rammensee H, Kanz L, Heni M
J CANCER RES CLIN. 2017;143(5):759-771.

Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation
Haen S, Groh C, Schumm M, Backert L, Löffler M, Federmann B, Faul C, Dörfel D, Vogel W, Handgretinger R, Kanz L, Bethge W
ANN HEMATOL. 2017;96(5):817-827.

An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia
Koerner S, André M, Leibold J, Kousis P, Kübler A, Pal M, Haen S, Bühring H, Grosse-Hovest L, Jung G, Salih H
LEUKEMIA. 2017;31(2):459-469.

Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols
Löffler M, Schuster H, Zeck A, Quilitz N, Weinreich J, Tolios A, Haen S, Horvath P, Löb S, Rammensee H, Königsrainer I, Königsrainer A, Beckert S
ANN SURG ONCOL. 2017;24(6):1650-1657.

The immunopeptidomic landscape of ovarian carcinomas
Schuster H, Peper J, Bösmüller H, Röhle K, Backert L, Bilich T, Ney B, Löffler M, Kowalewski D, Trautwein N, Rabsteyn A, Engler T, Braun S, Haen S, Walz J, Schmid-Horch B, Brucker S, Wallwiener D, Kohlbacher O, Fend F, Rammensee H, Stevanović S, Staebler A, Wagner P
P NATL ACAD SCI USA. 2017;114(46):E9942-E9951.

Hämatologischer Thoraxschmerz - Fall 3 / 2016
Haen S, Mannal R, Steeg M, Seizer P, Rockenstiehl M, Mackensen-Haen S, Horger M, Kanz L, Vogel W
DEUT MED WOCHENSCHR. 2016;141(9):634.

Allogeneic hematopoietic cell transplantation in patients ⩾70 years; which patients may benefit?
Haen S, Pham M, Faul C, Dörfel D, Vogel W, Kanz L, Bethge W
BLOOD CANCER J. 2016;6(7):e443.

Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab
Haen S, Schmiedel B, Rothfelder K, Schmied B, Dang T, Mirza N, Möhle R, Kanz L, Vogel W, Salih H
ONCOTARGET. 2016;7(11):13013-30.

Soluble heat shock protein 70 members in patients undergoing allogeneic hematopoietic cell transplantation
Mirza N, Prokop L, Kowalewski D, Gouttefangeas C, Faul C, Bethge W, Vogel W, Kanz L, Rammensee H, Haen S
TRANSPL IMMUNOL. 2016;36:25-31.

Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interaction
Mirza N, Zierhut M, Korn A, Bornemann A, Vogel W, Schmid-Horch B, Bethge W, Stevanović S, Salih H, Kanz L, Rammensee H, Haen S
P NATL ACAD SCI USA. 2016;113(48):13827-13832.

Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation
Haen S, Schumm M, Faul C, Kanz L, Bethge W, Vogel W
J CANCER RES CLIN. 2015;141(12):2241-51.

Choroidal metastases from thymic carcinoma during pregnancy: Case Report
Haen S, Stroebel P, Marx A, Suesskind D, Fend F, Reichmann U, Kopp H, Kanz L, Mayer F
BMC CANCER. 2015;15:972.

The repertoire of human tumor-associated epitopes--identification and selection of antigens and their application in clinical trials
Haen S, Rammensee H
CURR OPIN IMMUNOL. 2013;25(2):277-83.

Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia
Hofmann M, Große-Hovest L, Nübling T, Pyż E, Bamberg M, Aulwurm S, Bühring H, Schwartz K, Haen S, Schilbach K, Rammensee H, Salih H, Jung G
LEUKEMIA. 2012;26(6):1228-37.

Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation
Haen S, Gouttefangeas C, Schmidt D, Boss A, Clasen S, von Herbay A, Kosan B, Aebert H, Pereira P, Rammensee H
CELL STRESS CHAPERON. 2011;16(5):495-504.

More than just tumor destruction: immunomodulation by thermal ablation of cancer
Haen S, Pereira P, Salih H, Rammensee H, Gouttefangeas C
Clin Dev Immunol. 2011;2011:160250.

Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation
Widenmeyer M, Shebzukhov Y, Haen S, Schmidt D, Clasen S, Boss A, Kuprash D, Nedospasov S, Stenzl A, Aebert H, Wernet D, Stevanović S, Pereira P, Rammensee H, Gouttefangeas C
INT J CANCER. 2011;128(11):2653-62.

Particle size and activation threshold: a new dimension of danger signaling
Rettig L, Haen S, Bittermann A, von Boehmer L, Curioni A, Krämer S, Knuth A, Pascolo S
BLOOD. 2010;115(22):4533-41.

Fundus autofluorescence in multifocal choroiditis and panuveitis
Haen S, Spaide R
AM J OPHTHALMOL. 2008;145(5):847-53.

The white dot syndromes
Matsumoto Y, Haen S, Spaide R
Comprehensive ophthalmology update. 2007;8(4):179-200; discussion 203-4.

Letzte Aktualisierung aus dem FIS: 22.12.2024 - 03:53 Uhr